Erlotinib in Higher Risk Myelodysplastic Syndrome
Clinical trial NCT01085838 · COMPLETED
Trial details
- NCT number
- NCT01085838
- Sponsor
- Groupe Francophone des Myelodysplasies
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2014-03-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.